Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus

Staphylococcus aureus is a Gram-positive bacterium that has become the leading cause of hospital acquired infections in the US. Repurposing Food and Drug Administration (FDA) approved drugs for antimicrobial therapy involves lower risks and costs compared to de novo development of novel antimicrobia...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajamuthiah, Rajmohan, Fuchs, Beth Burgwyn, Conery, Annie L., Kim, Wooseong, Jayamani, Elamparithi, Kwon, Bumsup, Ausubel, Frederick M., Mylonakis, Eleftherios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405337/
https://www.ncbi.nlm.nih.gov/pubmed/25897961
http://dx.doi.org/10.1371/journal.pone.0124595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405337/
https://www.ncbi.nlm.nih.gov/pubmed/25897961
http://dx.doi.org/10.1371/journal.pone.0124595

Ejemplares similares